Evidence map›Paper›PMID 39055730›Full record

ReviewReumatologia2024

Usefulness in daily practice of the Systemic Lupus Erythematosus Disease Activity Index 2000 scale and the Systemic Lupus Erythematosus Disease Activity Score index for assessing the activity of systemic lupus erythematosus.

Dorota Suszek, Maciej Dubaj, Karol Bigosiński, Aleksandra Dembowska, Marcin Kaniewski, Wiktoria Sielwanowska, Bartosz Skierkowski, Izabela Dzikowska, Julia Sieczka, Maria Majdan

Abstract readReview
In one paragraph

Review in Reumatologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dorota SuszekChair and Department of Rheumatology and Connective Tissue Diseases, Medical University, Lublin, Poland.ORCID https://orcid.org/0000-0001-8131-6709
Maciej DubajStudent Scientific Circle at the Department of Rheumatology and Connective Tissue Diseases, Medical University, Lublin, Poland.
Karol BigosińskiStudent Scientific Circle at the Department of Rheumatology and Connective Tissue Diseases, Medical University, Lublin, Poland.
Aleksandra DembowskaStudent Scientific Circle at the Department of Rheumatology and Connective Tissue Diseases, Medical University, Lublin, Poland.
Marcin KaniewskiStudent Scientific Circle at the Department of Rheumatology and Connective Tissue Diseases, Medical University, Lublin, Poland.
Wiktoria SielwanowskaStudent Scientific Circle at the Department of Rheumatology and Connective Tissue Diseases, Medical University, Lublin, Poland.
Bartosz SkierkowskiStudent Scientific Circle at the Department of Rheumatology and Connective Tissue Diseases, Medical University, Lublin, Poland.
Izabela DzikowskaStudent Scientific Circle at the Department of Rheumatology and Connective Tissue Diseases, Medical University, Lublin, Poland.
Julia SieczkaStudent Scientific Circle at the Department of Rheumatology and Connective Tissue Diseases, Medical University, Lublin, Poland.
Maria MajdanChair and Department of Rheumatology and Connective Tissue Diseases, Medical University, Lublin, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by high heterogeneity of clinical manifestations and an uncertain prognosis. Although the mortality rate due to SLE has decreased significantly in recent decades, there is still a need to find good tools to measure disease activity for early detection of exacerbations and treatment planning. Over the decades, more than a dozen disease activity scales/indicators have been developed, with the SLE Disease Activity Index (SLEDAI) being the most popular. More recently, the new SLE Disease Activity Score (SLE-DAS) has been introduced. This paper compares the two methods of assessing SLE activity, and presents the relevance of these scales in pregnant SLE patients and their use in formulating definitions of remission and low disease activity. The results show that the SLEDAI and the SLE-DAS are of comparable value in assessing SLE activity and complement each other.

Indexed as

activity scalesSLESLEDAISLE-DAS

Identifiers

PMID39055730
PMCPMC11267658

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.